Latest news

Time | June 30, 2023

Dr. Andres Acosta, assistant professor of medicine at Mayo Clinic, has dedicated the past decade to developing a tailored approach to helping patients lose weight.

StarTribune | April 28, 2023

EXCERPT: Spun out of Mayo Clinic in 2018, Marani Health is piloting an in-home prenatal and postpartum care system that uses an artificial intelligence application for measuring the heart rates of pregnant women and their unborn fetus.

Mayo Clinic YouTube | April 17, 2023

The featured technology is now part of Anumana, a company formed by Mayo Clinic and nference, that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Pulse Magazine | April 2023 

EXCERPT: Vyriad and its older sibling, Imanis, are two of the many biotech firms that have spun out of Mayo Clinic since the organization started encouraging researchers to launch their own companies.

Post Bulletin | April 7, 2023

Vyriad is a biotech firm founded by Mayo Clinic researchers.

Becker’s Hospital Review | April 6, 2023

EXCERPT: Since 1986, when Mayo Clinic started keeping records, more than 7,000 inventors have disclosed 10,000 technologies (of which 4,000+ have been licensed to companies) and more than 300 startups have formed.

Mayo Clinic Discovery’s Edge | March 3, 2023

In 2019, Mayo Clinic and W. L. Gore & Associates formed a collaboration to advance the development of implantable cell therapies to treat debilitating conditions with no cure. Based on early research, the innovative investigational treatment is now showing real promise for patients.

Star Tribune | March 1, 2023

EXCERPT: While Mayo Clinic remains the region’s largest employer, the Rochester area has become a draw for biomedical companies in recent years. 

Mayo Clinic Individualized Medicine blog | February 27, 2023

Mayo Clinic executed a know-how license agreement with Maggie’s Pearl in 2021 to develop the first platform therapy for a group of related genetic inborn errors of metabolism called PMM2-CDG.

Post Bulletin | February 27, 2023

EXCERPT: Cytotheryx, co-founded by Exemplar Genetics and Mayo Clinic in 2018, announced that it has picked up the intellectual property assets of Ambys Medicines, Inc.

Becker’s Hospital Review | February 22, 2023

Clark C. Otley, M.D., is the Chief Medical Officer for Mayo Clinic Platform and the Medical Director for Mayo Clinic’s Department of Business Development.

Mayo Clinic Individualized Medicine blog | February 16, 2023

Adaptive Phage Therapeutics entered into an agreement with Mayo Clinic to commercialize a phage susceptibility test in June 2020.

MinnPost | February 14, 2023

EXCERPT: Minnesota, Olmsted County and the City of Rochester have committed $585 million over 20 years to stimulate an anticipated $5.6 billion of private investment that leverages Mayo Clinic’s legacy to make Rochester a global destination for health and wellness.

Forbes Healthcare | February 1, 2023

Because of the federated architecture, Mayo Clinic Platform partners can safely leverage deidentified data from a single, centralized place while accounting for data privacy, security and access rights.

Becker’s Healthcare | January 12, 2023

EXCERPT: Mayo Clinic and Kaiser Permanente were part of a $110 million funding round for Medically Home in January 2022 after becoming joint strategic investors the previous May.

Post Bulletin | January 6, 2023

EXCERPT: Mayo Clinic Chief Business Development Officer Jim Rogers spoke to highlight Mayo Clinic’s innovation, citing the launch or involvement with 32 startup companies in 2022 as well as that Mayo inventors have been issued 232 patents. 

Fierce Biotech | December 16, 2022

EXCERPT:  Originally launched in 2021 as a joint venture between nference and Mayo Clinic, Anumana will now work with Pfizer on a multiyear research project.

Healthcare Changemakers Podcast | November 30, 2022

Mayo Clinic News Network | November 29, 2022

Additional Sources: YouTubeApple PodcastsSpotify

Post Bulletin | October 20, 2022

EXCERPT:  “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.

BioSpace | September 20, 2022

EXCERPT:  MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19. 

Twin Cities Business | September 1, 2022

EXCERPT: Mayo Clinic Ventures chair Andrew Danielsen estimated that the accelerator will give birth to about one to three new companies a year.

Mass Device | August 1, 2022

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Med City News | July 15, 2022

EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Mass Devices | May 24, 2022

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.

Star Tribune | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer

Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

Business Wire | March 16, 2022

EXCERPT: Pramana’s first commercial agreement with Mayo Clinic is a multi-year collaboration that includes an industry-leading initiative to digitize 5 million slides – one of the largest digitization efforts in the world to date, at an unprecedented rate.

Star Tribune | February 7, 2022

EXCERPT: The company [Medical21] is collaborating with Mayo Clinic, which owns an equity stake in the company. Juan Crestanello, a cardiovascular surgeon at Mayo, said he and his colleagues have seen some of Medical 21’s work. “The results, so far, have been very encouraging,” Crestanello said. 

PR Newswire | January 19, 2022

EXCERPT: Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation. 

Star Tribune | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic.